It seems Galapagos 's stock trades with a discount. Many analysts say Galapagos is currently undervalued. Currently the company is being followed by 9 researchers. The recommendations for the stock contain no sells, 2 times hold and no buys. The average target price for the stock is at 101,22 euros. This is around 22 percent more than the current stock price of 84,24 euros. The most recent recommendations for the biotech company are from DeGroof Petercam, KBC Securities and UBS .
Galapagos 's market capitalization is based on the number of outstanding shares around 3,9 billion euros.
At 10.34 the stock trades 0,47 percent higher at 84,24 euros.
Analist.nl Nieuwsdienst: +31 084-0032-842
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.